Sally Pascall – Patient and Public Involvement representative
Sally was diagnosed with pancreatic cancer in April 2011. It proved to be operable and she underwent a pylorus preserving pancreatico-duodenectomy in May 2011, followed by 6 months of chemotherapy (gemcitabine). All appeared to be going well until in June/July 2012 when she was diagnosed with Type 3c diabetes and two peritoneal secondaries. There were no treatment options other than folfirinox, an experimental therapy. Sally managed to complete a six-month course of this despite suffering from several side effects. Having finished treatment she was found to have only one remaining metastasis which remarkably has remained unchanged since January 2013. She took early retirement from her work as a physiotherapist in the NHS during her second course of chemotherapy as it was assumed this would not have any long-lasting effect but she is very thankful to have remained extremely well since the end of her treatment.
Sally advises us on our programme strategy including PPI.